Tandem Diabetes Care, Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
Tandem Diabetes Care, Inc. (TNDM) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$952.00 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2024-11-06
- Tandem Diabetes Care, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2024-09-30 was -$1.19M.
- Tandem Diabetes Care, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2024-06-30 was $3.61M, a 44.26% decline year-over-year.
- Tandem Diabetes Care, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2024-03-31 was -$3.37M.
- Tandem Diabetes Care, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2023-09-30 was -$10.13M, a 229.14% decline year-over-year.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month |
|---|---|---|---|
| 2024-09-30 | -$1.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $2.42M derived: sum of 2 quarters · filed 2024-11-06 | -$952.00K 10-Q · filed 2024-11-06 |
| 2024-06-30 | $3.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $241.00K 10-Q · filed 2024-08-01 | |
| 2024-03-31 | -$3.37M 10-Q · filed 2024-05-02 | ||
| 2023-09-30 | -$10.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$3.65M derived: sum of 2 quarters · filed 2024-11-06 | -$4.57M 10-Q · filed 2024-11-06 |
| 2023-06-30 | $6.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $5.56M 10-Q · filed 2024-08-01 | |
| 2023-03-31 | -$919.00K 10-Q · filed 2024-05-02 | ||
| 2022-09-30 | $7.84M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $14.31M derived: sum of 2 quarters · filed 2023-11-01 | $28.04M 10-Q · filed 2023-11-01 |
| 2022-06-30 | $6.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $20.19M 10-Q · filed 2023-08-03 | |
| 2022-03-31 | $13.73M 10-Q · filed 2023-05-03 | ||
| 2021-09-30 | -$1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $39.00K derived: sum of 2 quarters · filed 2022-11-02 | $10.85M 10-Q · filed 2022-11-02 |
| 2021-06-30 | $1.14M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $11.96M 10-Q · filed 2022-08-03 | |
| 2021-03-31 | $10.81M 10-Q · filed 2022-05-04 | ||
| 2020-09-30 | $5.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $1.59M 10-Q · filed 2021-11-03 | |
| 2020-06-30 | -$3.78M 10-Q · filed 2021-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |